Identifying Peach and Plum Polyphenols with Chemopreventive Potential against Estrogen-Independent Breast Cancer Cells

被引:129
|
作者
Noratto, Giuliana [1 ,2 ]
Porter, Weston
Byrne, David [1 ,2 ]
Cisneros-Zevallos, Luis [1 ,2 ]
机构
[1] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA
[2] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX 77843 USA
关键词
Breast cancer; peaches; plums; chlorogenic acid; neo-chlorogenic acid; CHLOROGENIC ACID; PHENOLIC-COMPOUNDS; PHYTOCHEMICALS; CYTOTOXICITY; MECHANISMS;
D O I
10.1021/jf900259m
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Our objective was to evaluate the cancer suppression activity of extracts from a commercial variety of yellow-fleshed peach 'Rich Lady' (RL) and a red-fleshed plum 'Black Splendor' (BS) and identify the phenolic fractions that may possess potential as chemopreventive and/or chemotherapeutic natural compounds. The peach RL extract effectively inhibited the proliferation of the estrogen-independent MDA-MB-435 breast cancer cell line. The concentration to inhibit 50% of cell proliferation (IC50) was similar to 42 mg/L for-this cell line compared to an IC50 of similar to 130 and similar to 515 mg/L for the noncancerous breast cell line MCF-10A and the estrogen-dependent breast cancer cell line MCF-7, respectively. Similarly, BS extracts showed greater effects on MDA-MB-435 cells as compared to the other breast cancer or the normal breast cell lines. In general, BS extracts were less effective than RL extracts. Within all RL and BS fractions, fraction 3 (F3, flavonoids) and fraction 4 (F4, procyanidins) were more potent than fraction 1 (F1, phenolic acids) and fraction 2 (F2, anthocyanins) against the three cell lines. The order of potency of RL fractions against MDA-MB-435 was F-3 similar to F-4 > F-1 > F-2. The antiproliferative activity of pure compounds identified in F-3 and F-1 confirmed that quercetin 3 beta-glucoside is the bioactive compound in F-3, with the same level of toxicity on the estrogen-independent MDA-MB-435 breast cancer and breast epithelial MCF-10A cells (IC50 = 1.9 +/- 0.2 and 1.8 +/- 0.3, respectively). However, we confirmed that phenolic acids present in F-1: chlorogenic and neo-chlorogenic acids have potential as chemopreventive dietary compounds because of the relatively high growth inhibition exerted on the estrogen-independent MDA-MB-435 breast cancer cell line and low toxicity exerted in the normal MCF-10A cells.
引用
收藏
页码:5219 / 5226
页数:8
相关论文
共 50 条
  • [21] Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells
    Eric MJ Bindels
    François Lallemand
    Astrid Balkenende
    Desiree Verwoerd
    Rob Michalides
    Oncogene, 2002, 21 : 8158 - 8165
  • [22] C-MYC ONCOGENE EXPRESSION IN ESTROGEN-DEPENDENT AND ESTROGEN-INDEPENDENT BREAST-CANCER
    SHIU, RP
    WATSON, PH
    DUBIK, D
    CLINICAL CHEMISTRY, 1993, 39 (02) : 353 - 355
  • [23] Polyphenols of selected peach and plum genotypes reduce cell viability and inhibit proliferation of breast cancer cells while not affecting normal cells
    Vizzotto, Marcia
    Porter, Weston
    Byrne, David
    Cisneros-Zevallos, Luis
    Food Chemistry, 2014, 164 : 363 - 370
  • [25] Polyphenols of selected peach and plum genotypes reduce cell viability and inhibit proliferation of breast cancer cells while not affecting normal cells
    Vizzotto, Marcia
    Porter, Weston
    Byrne, David
    Cisneros-Zevallos, Luis
    FOOD CHEMISTRY, 2014, 164 : 363 - 370
  • [26] Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation
    Sikora, Matthew J.
    Strumba, Viktoriya
    Lippman, Marc E.
    Johnson, Michael D.
    Rae, James M.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1027 - 1039
  • [27] Aberrant P-cadherin expression: Is it associated with estrogen-independent growth in breast cancer?
    Paredes, J
    Milanezi, F
    Reis, JS
    Leitao, D
    Athanazio, D
    Schmitt, F
    PATHOLOGY RESEARCH AND PRACTICE, 2002, 198 (12) : 795 - 801
  • [28] Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation
    Matthew J. Sikora
    Viktoriya Strumba
    Marc E. Lippman
    Michael D. Johnson
    James M. Rae
    Breast Cancer Research and Treatment, 2012, 134 : 1027 - 1039
  • [29] Estrogen-independent effects of ER-α36 in ER-negative breast cancer
    Zhang, Jing
    Li, Guangliang
    Li, Zhongqi
    Yu, Xiongfei
    Zheng, Yi
    Jin, Ketao
    Wang, Haohao
    Gong, Yun
    Sun, Xiaoping
    Teng, Xiaodong
    Cao, Jiang
    Teng, Lisong
    STEROIDS, 2012, 77 (06) : 666 - 673
  • [30] Doxorubicin delivery systems with an acetylacetone-based block in cholesterol-terminated copolymers: Diverse activity against estrogen-dependent and estrogen-independent breast cancer cells
    Misiak, Pawel
    Niemirowicz-Laskowska, Katarzyna
    Misztalewska-Turkowicz, Iwona
    Markiewicz, Karolina H.
    Wielgat, Przemyslaw
    Car, Halina
    Wilczewska, Agnieszka Z.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2022, 245